HSP‐enriched properties of extracellular vesicles involve survival of metastatic oral cancer cells. Issue 9 (16th May 2018)

• Record Type: Journal Article
• Authors: Ono, Kisho; Eguchi, Takanori; Sogawa, Chiharu; Calderwood, Stuart K.; Futagawa, Junya; Kasai, Tomonari; Seno, Masaharu; Okamoto, Kuniaki; Sasaki, Akira; Kozaki, Ken‐ichi
• Is Part Of: Journal of cellular biochemistry. Volume 119:Issue 9(2018)
• Page Start: 7350
• Page End: 7362
• Publication Date: 2018-05-16
• Subjects: EV proteomics -- exosome -- extracellular vesicle -- heat shock proteins -- lymph‐node‐metastatic oral cancer -- molecular chaperone; Cytochemistry -- Periodicals; 572
• DOI: 10.1002/jcb.27039
• Languages: English
• ISSNs: 0730-2312

Abstract

Abstract: Cancer cells often secrete extracellular vesicles (EVs) that carry heat shock proteins (HSPs) with roles in tumor progression. Oral squamous cell carcinoma (OSCC) belongs to head and neck cancers (HNC) whose lymph‐node‐metastases often lead to poor prognosis. We have examined the EV proteome of OSCC cells and found abundant secretion of HSP90‐enriched EVs in lymph‐node‐metastatic OSCC cells. Double knockdown of HSP90α and HSP90β, using small interfering RNA significantly reduced the survival of the metastatic OSCC cells, although single knockdown of each HSP90 was ineffective. Elevated expression of these HSP90 family members was found to correlate with poor prognosis of HNC cases. Thus, elevated HSP90 levels in secreted vesicles are potential prognostic biomarkers and therapeutic targets in metastatic OSCC. Abstract : Cancer cells often secrete extracellular vesicles (EVs) that carry heat shock proteins (HSPs) with roles in tumor progression. Lymph‐node‐metastases of oral squamous cell carcinoma (OSCC) often lead to poor prognosis. Elevated HSP90 levels in secreted vesicles are potential prognostic biomarkers and therapeutic targets in metastatic OSCC.